Skip to content

Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment

Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02125942
Enrollment
15
Registered
2014-04-29
Start date
2014-04-30
Completion date
2015-09-30
Last updated
2021-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder

Keywords

Borderline Personality Disorder

Brief summary

Borderline personality disorder is a severe psychiatric disorder marked by emotional instability, difficulty with interpersonal relationships, and self-harming behaviors. Despite receiving psychotherapy for borderline personality disorder, studies show that patient recovery is slow, and there is a high rate of self injury and suicide attempts early in treatment. There is thus a clear need to provide therapies to augment psychotherapy. We will conduct a pilot trial to determine whether a 6-week Central Meditation and Imagery Therapy (CMIT) is feasible for subjects with borderline personality disorder to undergo when added on to psychotherapy treatment. CMIT is a non-validated therapy that combines principles of mindfulness with meditation techniques and guided imagery. Sessions led by a trained clinician in a group setting once a week, and participants are asked to complete daily home practice. The trial will involve 16 participants, all currently undergoing psychotherapy for borderline personality disorder. Participants will be randomly assigned to either a CMIT group that lasts 6 weeks, or a wait list group. Those in the wait list group will be able to receive CMIT after 6 weeks. All participants will continue to receive psychotherapy throughout the trial. During the trial, we will also obtain preliminary data to help understand whether CMIT may result in psychological benefits for participants. This will include measuring the pulse in order to determine variation in beat to beat intervals of the heart during psychological tests, and filling out questionnaires before and after participation in CMIT.

Interventions

mindfulness, guided imagery, meditation

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Meeting the diagnostic criteria for BPD according to DSM-IV criteria * Meeting the diagnostic criteria for BPD based on the Diagnostic Interview for Borderline - Revised * Currently receiving psychotherapy. * English language proficiency to understand written and oral communication

Exclusion criteria

* Active suicidality or suicidal intent as identified on the Columbia Suicide Severity Rating Scale * Suicide attempt within the past month

Design outcomes

Primary

MeasureTime frameDescription
Borderline Symptoms6 weeksBorderline Symptom List

Secondary

MeasureTime frameDescription
Depression6 weeksQuick Inventory of Depressive Symptoms
Anxiety6 weeksTrait Anxiety Inventory
Positive Affect6 weeksPositive and Negative Affect Scale

Other

MeasureTime frameDescription
Heart rate variability6 weeksResting heart rate variability

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026